PHRX (Pharmagen) Buyback Yield %: 0.00 (As of Jul. 12, 2026)


What is Pharmagen Buyback Yield %?

Pharmagen PHRX -90.00% Buyback Yield % is 0.00 as of Jul. 12, 2026.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Pharmagen's current buyback yield was 0.00%.

Pharmagen Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Pharmagen's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmagen Buyback Yield % Chart

Pharmagen Annual Data
Trend Jun10 Jun11 Dec12 Dec13
Buyback Yield %
0.00 0.00 0.00 0.00

Pharmagen Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PHRX vs FZMD, SNYR, SGMFF: Buyback Yield % Comparison

For the Medical Distribution subindustry, Pharmagen's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmagen Buyback Yield % vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Pharmagen's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Pharmagen's Buyback Yield % falls into.


Pharmagen Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Pharmagen's Buyback Yield for the fiscal year that ended in Dec. 2013 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 1.6941912
=0.00%

Pharmagen's annualized Buyback Yield for the quarter that ended in Mar. 2014 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 1.9169138
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
Pharmagen (PHRX) has a Buyback Yield % of 0.00 as of Jul. 12, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Pharmagen and its competitors.
Is Pharmagen's Buyback Yield % too high?
Pharmagen's current Buyback Yield % is 0.00.
How does Pharmagen's Buyback Yield % compare to FZMD and SNYR?
Pharmagen's Buyback Yield % of 0.00 can be compared against companies in the Medical Distribution industry. The industry median Buyback Yield % is 0.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Distribution company?
The median Buyback Yield % among Medical Distribution companies is 0.05, based on 39 companies in the industry. Companies in the top quartile (top 25%) have a Buyback Yield % significantly above this median, while those in the bottom quartile fall well below. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Pharmagen and its competitors. For the Medical Distribution industry, the median Buyback Yield % is 0.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmagen's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmagen stock overvalued right now?
Pharmagen (PHRX) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Pharmagen (PHRX), the current Buyback Yield % is 0.00 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmagen Business Description

Address 9337 Fraser Avenue, Silver Spring, MD, USA, 20910
Pharmagen Inc as a distributor of specialty drugs, compounding and admix pharmacy, and producer of over-the-counter branded multivitamins to the healthcare provider market. The company distributes hard-to-find and specialty drugs to the healthcare provider market throughout the United States, while functioning as an aggregator of real-time market demand for these products.